Metabolic Bone Disease
13
0
0
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.7%
1 terminated out of 13 trials
90.9%
+4.4% vs benchmark
8%
1 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (13)
A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method
Physical Therapy to Prevent Osteopenia in Preterm Infants
Bone Markers in Pediatric IF
The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.
Translational Development of Photon-counting CT Imaging
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates
Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants
The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.
Bariatric Surgery and Exercise Bone Trial
Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients
Markers of Bone Disease in Children on Parenteral Nutrition
Laparoscopic Revision From Biliopancreatic Diversion to Gastric Bypass